Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noel C Chan

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Medicine|February 15, 2021
Thromboembolism in Older AdultsPeter L Gross, Noel C Chan
Blood|March 30, 2019
MAA868 locks factor XIa in a zymogen-like stateJeffrey I Weitz, Noel C Chan
Blood|March 31, 2019
How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolismNoel C Chan, John W Eikelboom
European Heart Journal|October 14, 2021
Ciraparantag as a potential universal anticoagulant reversal agentNoel C Chan, Jeffrey I Weitz
Journal of the American College of Cardiology|October 26, 2019
Are Ticks the Answer to Medical Device-Associated Clotting?Jeffrey I Weitz, Noel C Chan
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2019
AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIaNoel C Chan, Jeffrey I Weitz
Thrombosis and Haemostasis|December 7, 2017
Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?Noel C Chan, Jeffrey I Weitz
Blood Advances|July 26, 2018
Antiplatelet therapy in the management of atherothrombosis: recent clinical advancesNoel C Chan, Jeffrey I Weitz
Arteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI InhibitorsNoel C Chan, Jeffrey I Weitz
Blood|January 10, 2020
Novel antithrombotic strategies for treatment of venous thromboembolismJeffrey I Weitz, Noel C Chan
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Medicine|February 15, 2021
Thromboembolism in Older AdultsPeter L Gross, Noel C Chan
Blood|March 30, 2019
MAA868 locks factor XIa in a zymogen-like stateJeffrey I Weitz, Noel C Chan
Blood|March 31, 2019
How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolismNoel C Chan, John W Eikelboom
European Heart Journal|October 14, 2021
Ciraparantag as a potential universal anticoagulant reversal agentNoel C Chan, Jeffrey I Weitz
Journal of the American College of Cardiology|October 26, 2019
Are Ticks the Answer to Medical Device-Associated Clotting?Jeffrey I Weitz, Noel C Chan
Arteriosclerosis, Thrombosis, and Vascular Biology|March 28, 2019
AB023, A Novel Antibody That Binds Factor XI and Blocks Its Activation by Factor XIIaNoel C Chan, Jeffrey I Weitz
Thrombosis and Haemostasis|December 7, 2017
Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?Noel C Chan, Jeffrey I Weitz
Blood Advances|July 26, 2018
Antiplatelet therapy in the management of atherothrombosis: recent clinical advancesNoel C Chan, Jeffrey I Weitz
Arteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI InhibitorsNoel C Chan, Jeffrey I Weitz
Blood|January 10, 2020
Novel antithrombotic strategies for treatment of venous thromboembolismJeffrey I Weitz, Noel C Chan
Pageof 7